The Argus II Retinal Prosthesis System has been approved by Health Canada to treat patients with severe to profound outer retinal degeneration, according to a press release from Second Sight Medical Products.The Argus II induces visual perception in bl…
Actavis and Allergan have announced that the U.S. Federal Trade Commission has allowed early termination of the Hart-Scott-Rodino Antitrust Improvement Act of 1976 waiting period with respect to Actavis’ pending acquisition of Allergan.The companies have set the close of business on Jan. 22 as the record date for determining shareholders that will be allowed to vote at their respective special meetings of shareholders, which will be held in connection with the pending acquisition, according to a press release.
Anti-LINGO-1, an investigational monoclonal antibody, showed evidence of biological repair of the visual system in the phase 2 acute optic neuritis RENEW trial, Biogen Idec announced in a press release.There was improvement in the recovery of optic ner…
NEW YORK – Reay H. Brown, MD, gives his pearls on adopting minimally invasive glaucoma surgery.
“I was blind as a bat,” said 73-year-old Parma, Ohio, resident John Barsa, who suffered from corneal edema, causing an abnormal accumulation of liquid in the eye leading to swelling of the cornea.
BOSTON — There have been major shifts in management of retinoblastoma in children, and children are living longer, David H. Abramson, MD, FACS, told colleagues at Macula 2015.“Everyone in this room has more than one genetic disease that he or she will transmit to his children. Every single one of us. Some of those genetic diseases will kill our progeny,” Abramson said.